Cargando…

Associations Between Long‐Term Fine Particulate Matter Exposure and Mortality in Heart Failure Patients

BACKGROUND: Environmental health risks for individuals with heart failure (HF) have been inadequately studied, as these individuals are not well represented in traditional cohort studies. To address this we studied associations between long‐term air pollution exposure and mortality in HF patients. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Ward‐Caviness, Cavin K., Weaver, Anne M., Buranosky, Matthew, Pfaff, Emily R., Neas, Lucas M., Devlin, Robert B., Schwartz, Joel, Di, Qian, Cascio, Wayne E., Diaz‐Sanchez, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335509/
https://www.ncbi.nlm.nih.gov/pubmed/32172639
http://dx.doi.org/10.1161/JAHA.119.012517
Descripción
Sumario:BACKGROUND: Environmental health risks for individuals with heart failure (HF) have been inadequately studied, as these individuals are not well represented in traditional cohort studies. To address this we studied associations between long‐term air pollution exposure and mortality in HF patients. METHODS AND RESULTS: The study population was a hospital‐based cohort of individuals diagnosed with HF between July 1, 2004 and December 31, 2016 compiled using electronic health records. Individuals were followed from 1 year after initial diagnosis until death or the end of the observation period (December 31, 2016). We used Cox proportional hazards models to evaluate the association of annual average fine particulate matter (PM (2.5)) exposure at the time of initial HF diagnosis with all‐cause mortality, adjusted for age, race, sex, distance to the nearest air pollution monitor, and socioeconomic status indicators. Among 23 302 HF patients, a 1 μg/m(3) increase in annual average PM (2.5) was associated with an elevated risk of all‐cause mortality (hazard ratio 1.13; 95% CI, 1.10–1.15). As compared with people with exposures below the current national PM (2.5) exposure standard (12 μg/m(3)), those with elevated exposures experienced 0.84 (95% CI, 0.73–0.95) years of life lost over a 5‐year period, an observation that persisted even for those residing in areas with PM (2.5) concentrations below current standards. CONCLUSIONS: Residential exposure to elevated concentrations of PM (2.5) is a significant mortality risk factor for HF patients. Elevated PM (2.5) exposures result in substantial years of life lost even at concentrations below current national standards.